FBRX Stock Analysis: Buy, Sell, or Hold?
FBRX - Forte Biosciences, Inc. Common Stock
$48.86
3.87 (8.60%)
▲
5d:
+11.25%
30d:
+184.9%
90d:
+55.46%
WAIT
LOW Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 13, 2026
25d
Get Alerted When FBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: FBRX is 33.9% above its trading range ($36.50). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: FBRX is 33.9% above its trading range ($36.50). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: FBRX is currently trading at $48.86, which is considered extended relative to its 30-day fair value range of $14.47 to $36.50.
Technical Outlook: Technically, FBRX is showing sideways momentum. The price is approaching resistance at $50.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.6% recently.
Market Sentiment: FBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $64.75 (+32.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBRX is showing sideways momentum. The price is approaching resistance at $50.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.6% recently.
Market Sentiment: FBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $64.75 (+32.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.47 -
$36.50
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price significantly overextended (+33.9% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.6%)
- BULLISH: Trading 32.5% below Wall St target ($64.75)
- WARNING: Recommendation downgraded due to 33.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$14.47 -
$36.50
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$12.17
(24.9%)
Support & Resistance Levels
Support Level
$19.95
Resistance Level
$50.00
Current Trend
Sideways
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.80
Wall Street Target
$64.75
(+32.5%)
Share & Embed Analysis
Last updated: July 18, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 52 HOLD |
